Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,235
Closed -$4.49M 1529
2026
Q1
$4.49M Buy
+8,235
New +$3.36M 0.04% 477
2025
Q3
Sell
-13,113
Closed -$2.89M 1483
2025
Q2
$2.89M Buy
+13,113
New +$2.36M 0.03% 609
2025
Q1
Sell
-6,499
Closed -$891K 1411
2024
Q4
$891K Buy
6,499
+3,803
+141% +$522K 0.01% 981
2024
Q3
$273K Sell
2,696
-8,073
-75% -$639K ﹤0.01% 1388
2024
Q2
$788K Buy
+10,769
New +$706K 0.01% 1097
2021
Q3
Sell
-5,656
Closed -$270K 2049
2021
Q2
$270K Sell
5,656
-20,979
-79% -$1.05M ﹤0.01% 1802
2021
Q1
$1.42M Buy
26,635
+21,292
+399% +$1.03M 0.02% 726
2020
Q4
$238K Buy
5,343
+425
+9% +$19.1K ﹤0.01% 1643
2020
Q3
$206K Buy
+4,918
New +$216K ﹤0.01% 1461
2020
Q1
Sell
-6,984
Closed -$280K 1044
2019
Q4
$280K Buy
+6,984
New +$269K 0.01% 1176

Other funds holding AGX

Michael Gelband's AGX Position: Q2 2026 in Review

Michael Gelband sold out of Argan (AGX) in Q2 2026, closing a stake of 8,235 shares — an estimated $4.49M sold.

Michael Gelband first reported a position in AGX in Q4 2019 and held it in 10 quarters. The position peaked at $4.49M in Q1 2026. 561 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

  • Michael Gelband reported no remaining Argan position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 8,235 Argan shares in Q2 2026, an estimated $4.49M.
  • Michael Gelband first reported a position in Argan in Q4 2019 and held it in 10 quarters.
  • Michael Gelband's Argan position peaked at $4.49M in Q1 2026.
  • 561 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.